PARP1 and cardiovascular disorder: Moreover, PARP activation, especially of PARP1, was previously found to be involved in various cardiovascular diseases other than AF11,12,15–17, and both pharmacological and genetic inhibition of PARP1 provides significant benefits in animal models of such cardiovascular disorders12,18.